Auranofin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Oral gold preparation; gold content: 29%.

Half-lifeThis section has been translated automatically.

408-600 hours

IndicationThis section has been translated automatically.

Rheumatoid arthritis, psoriatic arthritis.

Dosage and method of useThis section has been translated automatically.

6 mg in the morning or 2 times/day 3 mg p.o. If the response is insufficient after 4-6 months, 3 mg p.o. 3 times/day if necessary.

PreparationsThis section has been translated automatically.

Ridaura

Note(s)This section has been translated automatically.

An improvement of the symptoms can be expected after 3 months at the earliest!

Authors

Last updated on: 29.10.2020